NIH-funded research R01 grant

Understanding alpha-gal meat allergy and how the body's immune system reacts

Official title: Understanding alpha-gal red meat allergy

Funded at Univ of North Carolina Chapel Hill · NIH-11588253 · Data updated 2026-11-12

This grant studies why some people develop a dangerous allergy to meat due to a molecule called alpha-gal and how it triggers life-threatening reactions.

More Allergy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 24, 2018
Project endJanuary 31, 2029
Funding year2026
Award (this year)$321,666
NIH project number3R01AI135049-08S1
Project IDNIH-11588253 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 and older with or at risk for alpha-gal allergy, including older adults, may participate.

Less likely to help

People without alpha-gal allergy or related immune symptoms are unlikely to benefit directly.

What this research studies

Researchers will look at why some adults develop IgE antibodies to alpha-gal, a molecule in mammal meats, and whether the risk comes from genetics or tick exposure. They will use advanced single-cell sequencing and cell-surface markers to deeply profile the immune cells of adults with alpha-gal allergy. The goal is to map the immune pathways that lead to delayed and immediate anaphylaxis after meat or certain medications. Findings could reveal new targets for preventing or treating this unusual allergy.

Why it matters

Potential benefit: Understanding alpha-gal allergy could lead to better risk prediction and new strategies to prevent and treat life-threatening reactions.

How similar studies have gone: Prior work has linked alpha-gal IgE responses to allergic reactions; this project proposes deeper immune profiling to advance the field.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Commins, Scott Palmer — Univ of North Carolina Chapel Hill
  • Study coordinator: Commins, Scott Palmer

Related research

Other NIH-funded projects on the same topics.

  • New Horizons in preventing and treating food allergy

    A Johns Hopkins-led effort aims to advance how we prevent and treat food allergies across all ages by coordinating high-quality studies and developing better therapies.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11600582

  • Understanding antibiotic allergy to improve care for patients

    Scientists are testing new ideas to understand why some people develop severe allergic reactions to antibiotics and how to prevent or treat them.

    NIH research Brigham and Women's Hospital · Boston, United States · NIH-11593203

  • Antibiotic Allergy: Types, Triggers, and How they Work

    This grant aims to better understand why certain antibiotics trigger immediate allergic reactions and how to improve testing and diagnosis for patients with suspected antibiotic allergies.

    NIH research Mayo Clinic Jacksonville · Jacksonville, United States · NIH-11592359

  • New Horizons in Food Allergy Prevention and Treatment

    A large, multi-site program at Johns Hopkins aims to advance prevention and treatment of food allergies across all ages.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11580809

  • Food allergy outcomes by race/ethnicity from infancy through adolescence

    This study follows children with food allergies over time to understand how race and ethnicity relate to allergy management, outcomes, and quality of life.

    NIH research Northwestern University · Chicago, United States · NIH-11579222

  • Gut-brain links in food allergy responses

    A research grant is exploring how signals between the gut and brain drive dangerous reactions to foods, with the goal of helping people with food allergies.

    NIH research Yale University · New Haven, United States · NIH-11551492

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.